Ac Immune Sa (ACIU) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ac Immune Sa  (NASDAQ: ACIU)


Ac Immune Sa's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ac Immune Sa's ROI in the fourth quarter of 2025?
Ac Immune Sa recorded a cumulative net loss of $-111 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -136.32%.

Within the Healthcare sector 720 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4286.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -43.21 % -41.79 % -36.75 % -29.45 % -25.88 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 100 75 75 75 142
Return On Investment (TTM) -136.32 % -91.07 % -76.76 % -65.93 % -58.05 %
ACIU's Overall Ranking # 4286 # 0 # # #
Seq. Investment Change TTM -11.43 % -15.72 % -13.58 % -11.96 % -9.22 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -111 -84 -84 -83 -83

ACIU Company Profile >> Back to ACIU Roi Comparisons >> See Annual ACIU Return On Investment



Return On Investment ACIU's Ranking
Within: No.
Industry # 331
Sector # 721
Overall # 4286

Return On Investment Statistics
High Average Low
-30.24 %
-52.05 %
-118.28 %
(Dec 31 2021)   (Dec 31 2025)







Financial Statements
Ac Immune Sa's IV. Quarter Investments $ 100 Millions ACIU's Balance sheet
Ac Immune Sa's IV. Quarter Income $ -85 Millions Quarterly ACIU's Income Statement
ACIU's Income by Division See ACIU's Income by Division


ACIU Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 71 142 200 188 264
Y / Y Investment Growth -49.7 % -29.09 % 6.05 % -28.65 % 3.85 %
Net Income in Millions -85 -58 -60 -74 -80
Y / Y Net Income Growth - - - - -
Annual Return On Investment -119.38 % -40.84 % -30.24 % -39.37 % -30.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACIU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACIU's Competitors
Subscribers only: Roi for Ac Immune Sa's Suppliers
Subscribers only: Return On Investment for ACIU's Customers

Other Ratios
ACIU's Roa ACIU's Inventory Turnover Ratio ACIU's Growth Rates ACIU's Dividend Statistics
ACIU's Profitability Ratios ACIU's Asset Turnover Ratio ACIU's Dividend Growth
ACIU's Roe ACIU's Valuation Ratios ACIU's Financial Strength Ratios ACIU's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.